Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML

Blood (2024) 144 (1): 84–98.

https://doi.org/10.1182/blood.2024024072

Published: 2024

Includes: Supplemental data

Journal Articles

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Marion K Mateos, MBBS FRACP, Toby N Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Carly George, MBBS, FRACP, Rosemary Sutton, PhD, Tamas Revesz, MDPhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, FRACP, MBBS, Francoise Marie Mechinaud, MD FRACP, Daniel R Catchpoole, PhD BSc, Rishi Sury Kotecha, MBBChir, MRCP, FRACP, PhD, Michael CJ Quinn, BSc MSc PhD, Georgia Chenevix-Trench, BSc PhD, Stuart MacGregor, BSc MSc PhD, Luciano Dalla-Pozza, MBBS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2017) 130 (Supplement 1): 2102.

https://doi.org/10.1182/blood.V130.Suppl_1.2102.2102

Published: 2017

Journal Articles

Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL

Rosemary Sutton, PhD, Tamara Law, BSc (Hons), Nicola C Venn, BSc (Hons), Carol Wadham, PhD, Emily VA Mould, PhD, Murray D Norris, PhD, Rishi S Kotecha, MB ChB FRACP PhD, Rolf Marschalek, PhD, Claus Meyer, PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP, Richard B Lock, PhD, Toby N. Trahair, MBBS FRACP PhD

Blood (2016) 128 (22): 1740.

https://doi.org/10.1182/blood.V128.22.1740.1740

Published: 2016

Journal Articles

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Marion K Mateos, MBBS FRACP, Toby N. Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Rosemary Sutton, BSc PhD, Tamas Revesz, MD PhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, MBBS, FRACP, Francoise Mechinaud, MD FRACP, Daniel Catchpoole, BSc PhDFFSc(RCPA), Rishi S Kotecha, MB ChB FRACP PhD, Luciano Dalla-Pozza, MB BS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2016) 128 (22): 1182.

https://doi.org/10.1182/blood.V128.22.1182.1182

Published: 2016

Journal Articles

Increased Use of Allogeneic Transplant in CR2 Improves the Outcome for Children with Acute Myeloid Leukaemia

Aditi Vedi, MBBS, Richard Mitchell, MBBS FRACP, Cecelia Oswald, Glenn M Marshall, MBBS, MD FRACP, Toby Trahair, MBBS FRACP, David S. Ziegler, MBBS, FRACP, MD

Blood (2015) 126 (23): 2521.

https://doi.org/10.1182/blood.V126.23.2521.2521

Published: 2015

Journal Articles

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Pasquale M Barbaro, MBBS FRACP FRCPA, Marion Mateos, MBBS (Hons) BSc (MD FRACP, Luciano Dalla-Pozza, MB BS FRACP, Anthea Ng, BAppSc, MSc, Glenn M Marshall, MBBS, MD FRACP, Jodie E Giles, Rosemary Sutton, Rebecca Dagg, BSc (Hons), Loretta Lau, MBBS, MMed, PhD FRACP, Hilda A Pickett, BSc (Hons) PhD, Roger R Reddel, BSc (MD MBBS PhDFRACP FAA

Blood (2015) 126 (23): 4984.

https://doi.org/10.1182/blood.V126.23.4984.4984

Published: 2015

Journal Articles

Evaluation of Patient-Derived Xenografts for Modeling Outcome of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Abdulmohsen M Alruwetei, Msc, Hernan Carol, PhD, Rosemary Sutton, PhD, Glenn M Marshall, MBBS, MD FRACP, Richard B Lock, PhD

Blood (2015) 126 (23): 3759.

https://doi.org/10.1182/blood.V126.23.3759.3759

Published: 2015

Journal Articles

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

Blood (2015) 126 (23): 1419.

https://doi.org/10.1182/blood.V126.23.1419.1419

Published: 2015

Journal Articles

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia

Donya Moradi Manesh, Jad El-Hoss, Kathryn Evans, Jennifer Richmond, Cara E. Toscan, Lauryn S. Bracken, Ashlee Hedrick, Rosemary Sutton, Glenn M. Marshall, William R. Wilson, Raushan T. Kurmasheva, Catherine Billups, Peter J. Houghton, Malcolm A. Smith, Hernan Carol, Richard B. Lock

Blood (2015) 126 (10): 1193–1202.

https://doi.org/10.1182/blood-2014-12-618900

Published: 2015

Includes: Supplemental data

Journal Articles

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition

Blood (2010) 116 (16): 3013–3022.

https://doi.org/10.1182/blood-2010-05-284968

Published: 2010

Includes: Supplemental data

Journal Articles

Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition.

Richard B Lock, PhD, Petra S Bachmann, Rocco G Piazza, Carwyn Davies, Mary James, Nicholas C Wong, Vivek A Bhadri, Angela Mogavero, Vera Magistroni, Carlo Gambacorti-Passerini, Richard Saffery, Jeffrey M Craig, John E Pimanda, Glenn M Marshall

Blood (2009) 114 (22): 939.

https://doi.org/10.1182/blood.V114.22.939.939

Published: 2009

Journal Articles

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

Seoyeon Choi, Michelle J. Henderson, Edward Kwan, Alex H. Beesley, Rosemary Sutton, Anita Y. Bahar, Jodie Giles, Nicola C. Venn, Luciano Dalla Pozza, David L. Baker, Glenn M. Marshall, Ursula R. Kees, Michelle Haber, Murray D. Norris

Blood (2007) 110 (2): 632–639.

https://doi.org/10.1182/blood-2007-01-067785

Published: 2007

Journal Articles

Fludarabine, Idarubicin and High Dose Cytarabine (FLAG-IDA) Followed by Allogeneic Transplantation: A Successful Strategy for Remission Re-Induction in High Risk Pediatric Patients with Relapsed, Refractory and Secondary Acute Leukemias.

Melissa A. Gabriel, Tracey A. O’Brien, Heather Tapp, Barbara Chamberlain, Glenn M. Marshall, Richard J. Cohn, Cecelia Oswald, Susan J. Russell

Blood (2006) 108 (11): 3145.

https://doi.org/10.1182/blood.V108.11.3145.3145

Published: 2006

Journal Articles

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group

Tracey A. O'Brien, Susan J. Russell, Marcus R. Vowels, Cecilia M. Oswald, Karin Tiedemann, Peter J. Shaw, Liane Lockwood, Lochie Teague, Michael Rice, Glenn M. Marshall

Blood (2002) 100 (8): 2708–2716.

https://doi.org/10.1182/blood.V100.8.2708

Published: 2002

Journal Articles

The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse

Richard B. Lock, Natalia Liem, Monica L. Farnsworth, Christopher G. Milross, Chengyuan Xue, Mayamin Tajbakhsh, Michelle Haber, Murray D. Norris, Glenn M. Marshall, Alison M. Rice

Blood (2002) 99 (11): 4100–4108.

https://doi.org/10.1182/blood.V99.11.4100

Published: 2002

NARROW

Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Comparison of MRD Levels and Gene Expression Patterns in MLL-R Versus Non-MLL Infant ALL

Clinical Predictors of Venous Thromboembolism during Therapy for Childhood Acute Lymphoblastic Leukemia

Increased Use of Allogeneic Transplant in CR2 Improves the Outcome for Children with Acute Myeloid Leukaemia

Age Adjusted Telomere Length Decreases Following Treatment for Pediatric Acute Lymphoblastic Leukemia, but Does Not Predict Toxicity

Evaluation of Patient-Derived Xenografts for Modeling Outcome of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

High Prevalence of Relapse in Australian Children with Ph-like Acute Lymphoblastic Leukemia Despite Risk Adapted Treatment

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia

Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition

Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition.

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone

Fludarabine, Idarubicin and High Dose Cytarabine (FLAG-IDA) Followed by Allogeneic Transplantation: A Successful Strategy for Remission Re-Induction in High Risk Pediatric Patients with Relapsed, Refractory and Secondary Acute Leukemias.

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group

The nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only